EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Long‐term echocardiographic findings in patients with idiopathic recurrent pericarditis treated with anakinra

Zeynep Toker Dincer iD, Damla Raimoglou iD, Erkin Yilmaz iD, Ayten Dag iD, Melike Melikoglu iD, Serdal Ugurlu iD

Internal Medicine Journal · 2026-06 · 56 (6) · 1043-1050

DOI: 10.1111/imj.70452 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Internal Medicine Journal, online erschienen am 25.04.2026. Verfasst von Zeynep Toker Dincer und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey. Hauptthemen laut MEDLINE: Interleukin 1 Receptor Antagonist Protein, Echocardiography, Pericarditis, Antirheumatic Agents. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Idiopathic recurrent pericarditis (IRP) is considered an autoinflammatory disease, and interleukin 1 inhibitors, such as anakinra, are used to treat resistant cases. Constrictive pericarditis, a feared complication, continues to be a critical concern. In the biologic era, evidence on long‐term transthoracic echocardiographic (TTE) findings following anakinra treatment remains limited.

Methods

We conducted a cross‐sectional study that included 18 patients with IRP treated with anakinra who had been attack‐free for at least 3 months. TTE was performed on all patients and 21 healthy controls, and findings were compared between the groups.

Results

Pericardial thickness was significantly increased in patients compared with controls (3.1 mm (interquartile range (IQR): 3.0–3.4) vs 2.1 mm (IQR: 1.9–2.4), P < 0.001). None of the patients exhibited echocardiographic signs of constrictive pericarditis. Mild pericardial effusion was present in nine patients (50%) despite being attack‐free. Pericardial hyperechogenicity was observed in 61.1% of the patient group and 23.8% of the control group ( P = 0.018). In the subgroup analysis of patients receiving ongoing anakinra treatment and those who had discontinued, there were no significant differences in pericardial thickness ( P = 0.573), pericardial effusion ( P = 0.637) or pericardial hyperechogenicity ( P = 0.066).

Conclusion

In conclusion, despite the refractory course of the disease, no cases of constrictive pericarditis were identified. TTE evaluation revealed increased pericardial thickness in patients who received anakinra compared with healthy controls, despite being attack‐free. Further studies are needed to clarify whether the presence of pericardial thickening or ongoing pericardial effusion should influence treatment planning.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin 1 Receptor Antagonist ProteinEchocardiographyPericarditisAntirheumatic AgentsHumansFemaleMaleCross-Sectional StudiesMiddle AgedRecurrenceAdultAgedTime FactorsPericardial EffusionPericarditis, Constrictive

Stichwörter der Autor:innen

anakinraconstrictive pericarditisechocardiographyidiopathic recurrent pericarditispericardial thickness

Substanzen

Interleukin 1 Receptor Antagonist ProteinAntirheumatic Agents

Autor:innen und Institutionen

  • Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Department of Cardiology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.

ORCID-Profile: Zeynep Toker Dincer, Damla Raimoglou, Erkin Yilmaz, Ayten Dag, Melike Melikoglu, Serdal Ugurlu

Zitieren

APA

Toker Dincer, Z., Raimoglou, D., Yilmaz, E., Dag, A., Melikoglu, M., & Ugurlu, S. (2026). Long‐term echocardiographic findings in patients with idiopathic recurrent pericarditis treated with anakinra. Internal Medicine Journal, 56(6), 1043-1050. https://doi.org/10.1111/imj.70452

Vancouver

Toker Dincer Z, Raimoglou D, Yilmaz E, Dag A, Melikoglu M, Ugurlu S. Long‐term echocardiographic findings in patients with idiopathic recurrent pericarditis treated with anakinra. Internal Medicine Journal. 2026;56(6):1043-1050. doi:10.1111/imj.70452

BibTeX
@article{TokerDincer2026,
  author = {Toker Dincer, Zeynep and Raimoglou, Damla and Yilmaz, Erkin and Dag, Ayten and Melikoglu, Melike and Ugurlu, Serdal},
  title = {Long‐term echocardiographic findings in patients with idiopathic recurrent pericarditis treated with anakinra},
  journal = {Internal Medicine Journal},
  year = {2026},
  volume = {56},
  number = {6},
  pages = {1043--1050},
  doi = {10.1111/imj.70452}
}
Kostenlos starten →